Alzheimer's disease (AD) is a severe, chronic and progressive neurodegenerative disease
associated with memory and cognition impairment ultimately leading to death. It is the …

The average human life span in developed countries has increased to more than 80 years
following rapid breakthrough and developments in modern medicine and science, resulting …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder and is the most common
cause of progressive dementia in aging. Research on AD therapy has been partly …

Ethnopharmacological relevance Alzheimer's disease (AD), a deleterious
neurodegenerative disorder that impairs memory, cognitive functions and may lead to …

Alzheimer's disease (AD) is a common neurodegenerative brain disorder that causes
cellular response alterations, such as impaired cholinergic mechanism, amyloid-beta (Aβ) …

Alzheimer's disease (AD) is the most common neurodegenerative disorder to date, with no
curative or preventive therapy. Histopathological hallmarks of AD include deposition of β …

Despite extensive progress in understanding the pathology of Alzheimer's disease (AD) over
the last 50 years, clinical trials based on the amyloid–beta (Aβ) hypothesis have kept failing …

Negative psychological and physiological consequences of neurodegenerative disorders
represent a high social and health cost. Among the neurodegenerative disorders …

Alzheimer's disease (AD) is a generalized term used for the loss in memory and other
intellectual abilities on levels serious enough to interfere with daily life. It accounts for 60 …

Background—Alzheimer's disease (AD) is a multifactorial, progressive, neurodegenerative
disease that is characterized by memory loss, personality changes, and a decline in …